Ubs Group Ag Takeda Pharmaceutical CO LTD Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Ubs Group Ag holds 5,893,969 shares of TAK stock, worth $84.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,893,969

Previous 4,024,646 46.45%

Holding current value

$84.2 Million

Previous $62.2 Million 38.68%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$13.6 - $15.52 $25.4 Million - $29 Million	1,869,323 Added 46.45%	5,893,969 $86.3 Million
Q2 2025 Aug 14, 2025	BUY	$13.71 - $15.46 $31.1 Million - $35.1 Million	2,270,084 Added 129.38%	4,024,646 $62.2 Million
Q1 2025 May 13, 2025	BUY	$12.89 - $15.19 $1.2 Million - $1.41 Million	92,930 Added 5.59%	1,754,562 $26.1 Million
Q4 2024 Feb 14, 2025	BUY	$13.01 - $14.43 $20.7 Million - $22.9 Million	1,588,617 Added 2175.74%	1,661,632 $22 Million
Q3 2024 Nov 14, 2024	SELL	$13.0 - $15.08 $538,928 - $625,156	-41,456 Reduced 36.22%	73,015 $1.04 Million

Q2 2024 Aug 13, 2024	BUY	$12.6 - $13.67 $229,874 - $249,395	18,244 Added 18.96%	114,471 $1.48 Million
Q1 2024 May 13, 2024	BUY	$13.89 - $15.04 $460,286 - $498,395	33,138 Added 52.53%	96,227 $1.34 Million
Q4 2023 Feb 09, 2024	BUY	$13.36 - $15.43 $156,365 - $180,592	11,704 Added 22.78%	63,089 $900,000
Q3 2023 Nov 09, 2023	SELL	$15.03 - $16.32 $2.38 Million - $2.59 Million	-158,520 Reduced 75.52%	51,385 $794,000
Q2 2023 Aug 11, 2023	BUY	$15.57 - $17.11 $1.98 Million - $2.18 Million	127,439 Added 154.54%	209,905 $3.3 Million
Q1 2023 May 12, 2023	SELL	$15.28 - $16.48 $514,722 - $555,145	-33,686 Reduced 29.0%	82,466 $1.36 Million
Q4 2022 Feb 08, 2023	SELL	$12.42 - $15.62 $97,521 - $122,648	-7,852 Reduced 6.33%	116,152 $1.81 Million
Q3 2022 Nov 10, 2022	BUY	$12.8 - $28.65 $124,198 - $277,990	9,703 Added 8.49%	124,004 $1.61 Million
Q2 2022 Aug 10, 2022	BUY	$13.12 - $15.03 $103,661 - $118,752	7,901 Added 7.43%	114,301 $1.61 Million
Q1 2022 May 16, 2022	SELL	$13.54 - $15.35 $2.77 Million - $3.14 Million	-204,280 Reduced 65.75%	106,400 $1.52 Million
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $518,516 - $645,684	39,371 Added 14.51%	310,680 $4.23 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $17.26 $280,229 - $296,733	17,192 Added 6.77%	271,309 $4.44 Million
Q2 2021 Aug 13, 2021	SELL	$16.55 - $18.64 $216,225 - $243,531	-13,065 Reduced 4.89%	254,117 $4.28 Million
Q1 2021 May 12, 2021	BUY	$16.71 - $19.9 $2.78 Million - $3.32 Million	166,659 Added 165.79%	267,182 $4.88 Million
Q4 2020 Feb 11, 2021	BUY	$15.39 - $18.97 $262,845 - $323,988	17,079 Added 20.47%	100,523 $1.83 Million
Q3 2020 Nov 12, 2020	SELL	$17.1 - $19.19 $59,884 - $67,203	-3,502 Reduced 4.03%	83,444 $1.49 Million
Q2 2020 Jul 31, 2020	BUY	$14.59 - $19.5 $218,937 - $292,617	15,006 Added 20.86%	86,946 $1.56 Million
Q1 2020 May 01, 2020	BUY	$13.02 - $20.31 $8,801 - $13,729	676 Added 0.95%	71,940 $1.09 Million
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $54,657 - $67,447	-3,238 Reduced 4.35%	71,264 $1.41 Million
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $223,645 - $249,125	-13,848 Reduced 15.67%	74,502 $1.28 Million
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $2.26 Million - $2.79 Million	-136,367 Reduced 60.68%	88,350 $1.56 Million
Q1 2019 May 14, 2019	SELL	$16.7 - $21.52 $166 Million - $214 Million	-9,923,879 Reduced 97.79%	224,717 $4.58 Million
Q4 2018 Feb 14, 2019	BUY	$15.64 - $21.1 $159 Million - $214 Million	10,148,596 New	10,148,596 $171 Million

Others Institutions Holding TAK

# of Institutions

385

Shares Held

80.7M

Call Options Held

1.67M

Put Options Held

276K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.4B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account